(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






654 Result: Form 10-K

Qualcomm Extends Cash Tender Offer for All Outstanding Shares of NXP

February 06th, 2017

- NXP Shareholders Approve All Items Proposed Relating To Qualcomm’s Tender Offer - SAN DIEGO / CRWE PRESS RELEASE / Feb. 6, 2017 - Qualcomm Incorporated (NASDAQ: QCOM) today announced that Qualcomm River Holdings B.V. , an indirect wholly o. Read more

EyeGate Pharma Announces Positive Top-line Data from First-in-Human Pilot Trial of Ocular Bandage Gel in Corneal Epithelial Defects

January 30th, 2017

Company Plans to Continue Development with Next Controlled Trial Q2 2017 WALTHAM, Mass. / CRWE PRESS RELEASE / January 30, 2017 - EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a specialty pharma. Read more

Walgreens Boots Alliance and Rite Aid Enter into Amendment and Extension to Merger Agreement

January 30th, 2017

Deerfield, Ill. and Camp Hill, Pa. / CRWE PRESS RELEASE / January 30, 2017 - Walgreens Boots Alliance, Inc. (Nasdaq: WBA) and Rite Aid Corporation (NYSE: RAD) today announced that they have entered into an amendment and extension of their previously . Read more

EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437

January 09th, 2017

WALTHAM, Mass. / CRWE PRESS RELEASE / January 9, 2017 - EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing pro. Read more

Puma Biotechnology Expands Cohort in Phase II SUMMIT Trial of PB272 in HER2 Mutation-Positive Cancer Patients

January 06th, 2017

LOS ANGELES, Calif. / CRWE PRESS RELEASE / Jan. 6, 2017 - Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, has expanded the fourth cohort from its Phase II SUMMIT clinical trial of its lead drug candidate PB272 (neratinib) as a s. Read more

Ritter Pharmaceuticals Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published in Proceedings of the National Academy of Science

January 03rd, 2017

LOS ANGELES, CA / CRWE PRESS RELEASE / January 3, 2017 - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the human gut micro. Read more

Fred's Pharmacy Agrees to Acquire 865 Rite Aid Stores

December 20th, 2016

Purchase Would Create Third-Largest U.S. Drug Store Chain and Support Healthcare Growth Strategy MEMPHIS, Tenn. / CRWE PRESS RELEASE / December 20, 2016 – Fred’s Inc. (“Fred’s Pharmacy” or “the Company”) (. Read more

Uranium Resources Signs Binding Amendment for Sale of Assets

December 14th, 2016

CENTENNIAL, Colo. / CRWE PRESS RELEASE / December 14, 2016 - Uranium Resources, Inc. (Nasdaq: URRE; ASX: URI), an energy metals exploration and development company, has entered into a binding amendment to the Share Purchase Agreement (“Agreemen. Read more

vTv Therapeutics Announces Positive Topline Results from Phase 2 Study of TTP273 in Type 2 Diabetes

December 14th, 2016

Oral small molecule GLP-1 receptor agonist met primary endpoint Company’s second successful Phase 2 diabetes trial in 2016 High Point, North Carolina / CRWE PRESS RELEASE / December 14, 2016 - vTv Therapeutics Inc. (vTv) (Nasdaq: VTVT) to. Read more

Anavex Life Sciences Announces 12-Month Data of ANAVEX 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer's Disease Patients

December 08th, 2016

Data presentation at CTAD 2016 NEW YORK, NY / CRWE PRESS RELEASE / December 8, 2016 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL) today announced a positive 57-week update from its . Read more

Puma Biotechnology Presents Results of Biomarker Analysis of Phase II Trial of PB272 in Neoadjuvant Treatment of HER2-Positive Locally Advanced Breast Cancer at the 2016 San Antonio Breast Cancer Symposium

December 07th, 2016

LOS ANGELES, Calif. / CRWE PRESS RELEASE / December 7, 2016 - Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that a biomarker analysis of the NSABP FB-7 Phase II clinical trial of Puma's investigational drug PB. Read more

Puma Biotechnology Presents Interim Results of Phase II Trial of PB272 for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2016 San Antonio Breast Cancer Symposium

December 07th, 2016

LOS ANGELES, Calif. / CRWE PRESS RELEASE / December 7, 2016 - Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that updated interim results from an ongoing Phase II clinical trial of Puma's investigational drug P. Read more

Crown Equity Holdings Inc. (CRWE) Announces the Completion of its 2016 Quarterly Audits

November 29th, 2016

LAS VEGAS, NV / CRWE PRESS RELEASE / November 29, 2016 - Crown Equity Holdings Inc. (CRWE) announced today that accounting firm MaloneBailey, LLP has completed its audits, making the company current with its 2016 quarterly filings. The company als. Read more

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

October 27th, 2016

CorPath® GRX enhances procedural control and improves workflow, bringing added benefits to robotic-assisted coronary interventions Waltham, MA / CRWE PRESS RELEASE / October 27, 2016 - Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leadi. Read more

Aralez to Acquire From AstraZeneca U.S. Rights to Beta Blocker Toprol-XL(R)

October 04th, 2016

-On an Adjusted EBITDA Basis, Transaction Expected to be EBITDA Accretive and to Move Profitability Forward to 2017- -Company to Host Conference Call on October 4, 2016 at 8:30 a.m. ET- MISSISSAUGA, Ontario / CRWE PRESS RELEASE / October 4, 201. Read more

Load More Content